Sergey A. Kaliberov

1.1k total citations · 1 hit paper
25 papers, 825 citations indexed

About

Sergey A. Kaliberov is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Sergey A. Kaliberov has authored 25 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 14 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Sergey A. Kaliberov's work include Virus-based gene therapy research (18 papers), Cancer Research and Treatments (9 papers) and CAR-T cell therapy research (8 papers). Sergey A. Kaliberov is often cited by papers focused on Virus-based gene therapy research (18 papers), Cancer Research and Treatments (9 papers) and CAR-T cell therapy research (8 papers). Sergey A. Kaliberov collaborates with scholars based in United States, United Kingdom and Belgium. Sergey A. Kaliberov's co-authors include Lyudmila N. Kaliberova, David T. Curiel, Sergei Kusmartsev, Victor Prima, Donald J. Buchsbaum, Valentina Krendelchtchikova, Cecil R. Stockard, William E. Grizzle, Jeffrey M. Arbeit and G. Yancey Gillespie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Virology.

In The Last Decade

Sergey A. Kaliberov

24 papers receiving 816 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

COX2/mPGES1/PGE ₂ pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells

2017 374 citations Victor Prima, Lyudmila N. Kaliberova et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sergey A. Kaliberov United States	15	368	304	273	213	123	25	825
Lyudmila N. Kaliberova United States	15	398 1.1×	336 1.1×	294 1.1×	260 1.2×	129 1.0×	24	878
Aleksandra M. Michalowska United States	10	493 1.3×	565 1.9×	215 0.8×	73 0.3×	172 1.4×	12	914
Lucia Mazzacurati United States	14	550 1.5×	387 1.3×	128 0.5×	206 1.0×	120 1.0×	22	956
Cecilia Larocca United States	12	610 1.7×	303 1.0×	253 0.9×	98 0.5×	62 0.5×	37	1.0k
Elizabeth K. Duperret United States	18	474 1.3×	435 1.4×	476 1.7×	82 0.4×	143 1.2×	25	1.1k
Yunping Lu China	18	762 2.1×	287 0.9×	125 0.5×	101 0.5×	324 2.6×	77	1.1k
Roopa Srinivasan United States	11	384 1.0×	399 1.3×	771 2.8×	91 0.4×	26 0.2×	17	1.0k
Jinfa Gu China	16	552 1.5×	291 1.0×	103 0.4×	417 2.0×	127 1.0×	33	809
C. Sheehan Canada	9	364 1.0×	328 1.1×	363 1.3×	51 0.2×	150 1.2×	9	818
Jay S. Lillquist United States	15	499 1.4×	160 0.5×	157 0.6×	131 0.6×	80 0.7×	23	857

Countries citing papers authored by Sergey A. Kaliberov

Since Specialization

Citations

This map shows the geographic impact of Sergey A. Kaliberov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergey A. Kaliberov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergey A. Kaliberov more than expected).

Fields of papers citing papers by Sergey A. Kaliberov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergey A. Kaliberov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergey A. Kaliberov. The network helps show where Sergey A. Kaliberov may publish in the future.

Co-authorship network of co-authors of Sergey A. Kaliberov

This figure shows the co-authorship network connecting the top 25 collaborators of Sergey A. Kaliberov. A scholar is included among the top collaborators of Sergey A. Kaliberov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergey A. Kaliberov. Sergey A. Kaliberov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Prima, Victor, Lyudmila N. Kaliberova, Sergey A. Kaliberov, David T. Curiel, & Sergei Kusmartsev. (2017). COX2/mPGES1/PGE ₂ pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells. Proceedings of the National Academy of Sciences. 114(5). 1117–1122. 374 indexed citations breakdown →

Sharma, Piyush Kumar, Igor P. Dmitriev, Elena A. Kashentseva, et al.. (2017). Development of an adenovirus vector vaccine platform for targeting dendritic cells. Cancer Gene Therapy. 25(1-2). 27–38. 30 indexed citations

Lu, Zhi Hong, Sergey A. Kaliberov, Rebecca Sohn, et al.. (2017). A new model of multi-visceral and bone metastatic prostate cancer with perivascular niche targeting by a novel endothelial specific adenoviral vector. Oncotarget. 8(7). 12272–12289. 8 indexed citations

Wambach, Jennifer, Ping Yang, Daniel Wegner, et al.. (2016). Functional Characterization of ATP-Binding Cassette Transporter A3 Mutations from Infants with Respiratory Distress Syndrome. American Journal of Respiratory Cell and Molecular Biology. 55(5). 716–721. 46 indexed citations

Kaliberov, Sergey A., et al.. (2016). Retargeted adenoviruses for radiation-guided gene delivery. Cancer Gene Therapy. 23(9). 303–314. 13 indexed citations

Erp, Elisabeth A. van, Lyudmila N. Kaliberova, Sergey A. Kaliberov, & David T. Curiel. (2015). Retargeted oncolytic adenovirus displaying a single variable domain of camelid heavy-chain-only antibody in a fiber protein. Molecular Therapy — Oncolytics. 2. 15001–15001. 18 indexed citations

Lu, Zhi Hong, Sergey A. Kaliberov, Jingzhu Zhang, et al.. (2014). The myeloid-binding peptide adenoviral vector enables multi-organ vascular endothelial gene targeting. Laboratory Investigation. 94(8). 881–892. 18 indexed citations

Kaliberov, Sergey A., Lyudmila N. Kaliberova, Donald J. Buchsbaum, & David T. Curiel. (2014). Experimental virotherapy of chemoresistant pancreatic carcinoma using infectivity-enhanced fiber-mosaic oncolytic adenovirus. Cancer Gene Therapy. 21(7). 264–274. 4 indexed citations

Kaliberov, Sergey A., Lyudmila N. Kaliberova, Maurizio Buggio, et al.. (2014). Adenoviral targeting using genetically incorporated camelid single variable domains. Laboratory Investigation. 94(8). 893–905. 13 indexed citations

10.

Kaliberov, Sergey A., Lyudmila N. Kaliberova, Zhi Hong Lu, et al.. (2013). Retargeting of gene expression using endothelium specific hexon modified adenoviral vector. Virology. 447(1-2). 312–325. 20 indexed citations

11.

Kaliberova, Lyudmila N., Sergei Kusmartsev, Valentina Krendelchtchikova, et al.. (2009). Experimental cancer therapy using restoration of NAD+-linked 15-hydroxyprostaglandin dehydrogenase expression. Molecular Cancer Therapeutics. 8(11). 3130–3139. 26 indexed citations

12.

Kaliberova, Lyudmila N., Valentina Krendelchtchikova, Cecil R. Stockard, et al.. (2009). CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma. Cancer Gene Therapy. 16(10). 794–805. 26 indexed citations

13.

Kaliberov, Sergey A., G. Yancey Gillespie, Valentina Krendelchtchikova, et al.. (2007). Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma. Gene Therapy. 14(14). 1111–1119. 26 indexed citations

14.

Kaliberov, Sergey A. & Donald J. Buchsbaum. (2005). Gene delivery and gene therapy of prostate cancer. Expert Opinion on Drug Delivery. 3(1). 37–51. 4 indexed citations

15.

Kaliberov, Sergey A., Lyudmila N. Kaliberova, Valentina Krendelchtchikova, et al.. (2005). Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity. Cancer Gene Therapy. 13(2). 203–214. 21 indexed citations

16.

Kaliberov, Sergey A., Lyudmila N. Kaliberova, Cecil R. Stockard, William E. Grizzle, & Donald J. Buchsbaum. (2004). Adenovirus-mediated FLT1-targeted proapoptotic gene therapy of human prostate cancer. Molecular Therapy. 10(6). 1059–1070. 21 indexed citations

17.

Kaliberov, Sergey A., Lyudmila N. Kaliberova, & Donald J. Buchsbaum. (2004). Combined ionizing radiation and sKDR gene delivery for treatment of prostate carcinomas. Gene Therapy. 12(5). 407–417. 19 indexed citations

18.

Kaliberov, Sergey A., et al.. (2004). Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells. Gene Therapy. 11(8). 658–667. 13 indexed citations

19.

Kaliberov, Sergey A., Donald J. Buchsbaum, G. Yancey Gillespie, et al.. (2002). Adenovirus-Mediated Transfer of BAX Driven by the Vascular Endothelial Growth Factor Promoter Induces Apoptosis in Lung Cancer Cells. Molecular Therapy. 6(2). 190–198. 27 indexed citations

20.

Kaliberov, Sergey A., et al.. (1993). [The immunity indices in the infection of mice of different strains with the Machupo virus].. PubMed. 38(4). 167–70. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact